Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
DOI

10.1093/cid/ciw077

Type

Journal article

Journal

Clin Infect Dis

Publication Date

01/05/2016

Volume

62

Pages

1193 - 1194

Keywords

Anti-Bacterial Agents, Cost-Benefit Analysis, Humans, Mupirocin, Risk, Staphylococcal Infections, Staphylococcus aureus